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Summary.-Leucocytes containing a high proportion of blast cells were obtained
from 11 patients with acute myeloid leukaemia, and leucocytes were also obtained
from 2 normal subjects. Ferritin was partially purified from leucocyte extracts
and subjected to anion-exchange chromatography and isoelectric focusing. The Fe
content of leucocyte ferritin was low, and in all but one case the preparations con-
tained isoferritins corresponding to those found in normal tissues or serum. Only
some of the preparations contained the relatively acidic isoferritins which have
been described as " carcinofoetal ", but which are also present in normal heart and
kidney. Ferritin from one patient contained isoferritins of lower isoelectric point
than heart ferritin. These results show that there does not appear to be any specific
isoelectric focusing pattern for leukaemic cells, and that assays for acidic isoferritins
are unlikely to be of use in the diagnosis of leukaemia and in monitoring treatment.
However, the very acidic protein found in one preparation suggests that the search
for abnormal subunits of ferritin may be fruitful in acute leukaemia.
SERUM ferritin concentrations are nor-
mally related to the amount of storage
Fe in the body. However, in pathological
conditions, high concentrations of cir-
culating ferritin may be present, either
because ofabnormal release from damaged
cells or because of abnormal synthesis
of the protein (Jacobs and Worwood,
1975). Acute leukaemia may be an
example of both " pathological " mech-
anisms as, in addition to increased cellular
destruction, circulating leukaemic cells
may synthesize increased amounts of
ferritin (White et al., 1974) and contain
higher concentrations of ferritin than
normal leucocytes (Worwood et al., 1974).
Serum ferritin concentrations are high
in children and adults with acute leuk-
aemia, both at presentation and during
chemotherapy, but return to the normal
range in children who have been success-
fully treated and are no longer receiving
chemotherapy (Parry, Worwood and Ja-
cobs, 1975). These observations sug-
gested that the assay of serum ferritin
may be of use in predicting the onset of
haematological relapse in such children.
On isoelectric focusing, ferritin is seen
to consist of a number of " isoferritins ",
some of which are common to all tissues
(Powell et al., 1975a). The more acidic
isoferritins are found in heart and kidney
(Powell et al., 1975a), in placenta
(Drysdale and Singer, 1974) and foetal
tissues (Alpert, Coston and Drysdale,
1973), in hepatoma (Alpert et al., 1973),
in carcinoma of the breast and pancreas
(Marcus and Zinberg, 1974) and in HeLa
cells (Drysdale and Singer, 1974). Such
acidic isoferritins, when appearing in
tissues which do not normally contain
them, such as liver, have been called
" carcinofoetal " ferritin (Alpert et al.,
1973). Acidic ferritin from heart can
be distinguished from liver or spleen
ferritin immunologically (Arosio, Yokota
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and Drysdale, 1976; Marcus and Zinberg,
1975; Worwood, Jones and Jacobs, 1976b)
and there is the possibility of developing
specific assays for acidic isoferritins which
may be of value in the study of malig-
nancy. In order to assess the significance
of carcinofoetal ferritin in leukaemia we
have purified ferritin from leukaemic
cells of patients with acute myeloid
leukaemia and compared this ferritin
with ferritin purified from normal tissues
and blood cells.
METHODS
Patients.-Cells were obtained from un-
treated patients presenting with acute mye-
loid leukaemia with a white blood cell count
of > 40 x 109/1. On admission, initial blood
transfusions were accompanied by the re-
movalof400-500ml bloodwhichwas collected
in heparin for preparation of a leukaemic
cell extract. In one case about 1011 leuco-
cytes were obtained using the Celltrifuge
Blood Cell Separator (American Instrument
Co., Silver Spring, Maryland, 20910).
Normal subjects.-Two fully informed
members of the hospital staff agreed to
denote normal leucocytes, and about 1010
cells were obtained in each case, using the
cell separator.
Preparation of leucocyte extracts from
whole blood.-400-500 ml blood was collected
in heparin and centrifuged at 1500 g for
20 min. The plasma was removed and the
cells were resuspended in 400 ml of 3%
dextran in 0-9% NaCl (Dextraven 150,
Fisons Ltd., Loughborough, UK). After
gentle mixing, the blood cells were allowed
to sediment under gravity at room tempera-
ture until a distinct red cell layer formed at
the bottom of the measuring cylinder. The
supernatant, containing leucocytes, platelets
and erythrocytes, was removed and centri-
fuged at 180 g for 5 min in 100-ml tubes.
The supernatant was discarded, and the
pellet (erythrocytes and leucocytes) was
washed twice in saline by centrifugation at
500 g for 5 min. Red cells were lysed by
resuspending the cell pellet in 100 ml 0.9%
NaCl and adding 300 ml ice-cold distilled
water. After mixing for 30 s, 100 ml 3-5%
NaCl solution was added, and the suspension
mixed immediately to restore isotonicity.
After two further washings in 0-9% NaCl,
the leucocytes were suspended in 100 ml
0-9% NaCl and a sample was taken for a
cell count. The cells were disrupted by
sonication (MSE Ltd., Crawley, UK) and
centrifuged at 18,000g for 30 min. The
supernatant was then frozen and stored at
-200C.
Preparation of leucocyte extracts with cells
obtained from the separator.-The cells were
collected in a blood bag in heparinized
plasma. The red: white cell ratio was about
2: 1 in the case of the patients with leuk-
aemia, and 75: 1 for the normal subjects.
The bag was centrifuged at 1500 g for 20 min
and the plasma was removed. The normal
cells were resuspended in 400 ml of 3%
dextran in 0-9% NaCl as described above,
and red cells were allowed to sediment.
This stage was omitted for leukaemic cells.
The leucocytes were then washed twice in
0-9% NaCl, and lysis of red cells was carried
out as described above. The cells were
disrupted in a Waring blender operated at
maximum speed for 1 min and the super-
natant obtained after centrifugation at
18,000 g for 30 min, was stored at -20°C.
Partial purification of leucocyte ferritin.-
The leucocyte extract was rapidly heated
to 700C in a water bath at 85TC and main-
tained at 70-750C for a total heating time
of 10 min. After cooling, the suspension was
centrifuged at 18,000 g for 30 min. The
supernatant was adjusted to pH 4-8 by
adding solid sodium acetate (0-025 M) and
then adding 1 M acetic acid drop-wise with
stirring. After standing at 40C for at least
2 h, precipitated protein was removed by
further centrifugation at 18,000 g for 30 min.
Solid sodium azide (0 02%) was added to
the supernatant, and the pH was carefully
adjusted to 6-8 by drop-wise addition of
1 M NaOH with stirring. The solution was
concentrated to about 5 ml by ultrafiltration
(UMIO membrane, Amicon Ltd., High Wy-
combe, Bucks.) and subjected to gel filtration
on a 90 x 2X5-cm column of Sepharose 6B
(Pharmacia (GB) Ltd., London W5) in
0 05 M phosphate buffer, pH 7 5, containing
0 02% sodium azide. The fractions con-
taining ferritin (detected by the immuno-
radiometric assay) were combined and con-
centrated to a volume of about 5 ml.
Anion - exchange chromatography. - The
concentrated solution obtained after gel
filtration was dialysed against barbiturate
buffer, pH 6-8, and subjected to anion-ISOFERRITINS IN ACUTE LEUKAEMIA
TABLE I.-Haematological and Biochemical Datafrom Patients with Leukaemia
Leuco-
cyte Platelet Blast Nucleated Serum Muram- Leucoc;
atient Hb count count cells red cells ferritin Asp. T idase ferriti
(sex) Diagnosis (g/dl) (109/1) (109/1) % % rg/l iu/l sg/ml fg/cel
I (M) AML 10-3 47 9 51 15 337 36 39 32
2 (F) CML 10-6 96 165 92 0 195 13 235 13
(F)
(F)
(M)
(M)
(M)
(M)
(M)
(M)
(M)
(blast
phase)
AML
AML
AML
AMML
AMML
AMML
AMML
AMML
AMML
13 -4
10 -4
8-3
10-0
10 -3
6-7
13 -5
10-8
10-0
73
46
69
115
61
71
44
86
128
150
105
74
40
87
61
25
9
20
93
86
88
93
71
76
84
0
0
0
0
0
2
5
94
528
673
1651
3110
2057
2298
2097
10400
26 9
15 33
32
275
23 235
47 175
50 460
20
100 235
byte
in
11
9
22
34
27
53
80
189
131
44
exchange chromatography on Sephadex A-50
(Worwood et at., 1976a). Ferritin was
detected in the fractions by immunoradio-
metric assay and all fractions containing
ferritin were combined and concentrated.
Other experimental methods.-Density-gra-
dient centrifugation was carried out by the
method of Worwood et at. (1975) and iso-
electric focusing in polyacrylamide gel rods
as described by Worwood et al. (1976a).
Ferritin was detected in the gels by direct
staining with Coomassie blue, by immuno-
precipitation and by staining for Fe (Wor-
wood et al., 1976a). Ferritin was assayed
by an automated version of the immuno-
radiometric assay (Jones and Worwood,
1975). Protein was measured by the method
of Lowry et al. (1951) using bovine serum
albumin as standard. Leucocytes were
counted with the Coulter Model S (Coulter
Electronics Ltd., Harpenden, Herts., UK),
and other haematological methods were
standard (Dacie and Lewis, 1975). Serum
muramidase activity was measured by the
method of Parry, Chandon and Shahani
(1965). Serum aspartate transaminase and
alpha-hydroxybutyrate dehydrogenase ac-
tivity were measured in the Department of
Medical Biochemistry, University Hospital
of Wales. Fe-rich preparations of normal
human liver and heart ferritin were prepared
as described by Worwood et al. (1975).
RESULTS
Haematological and biochemical data from
patients with leukaemia
Blood was taken from 11 patients
with acute myeloid leukaemia. Four
patients presented with acute myeloblastic
leukaemia (AML), and 6 with acute
myelomonocytic leukaemia (AMML). One
patient with chronic myeloid leukaemia
(CML) presented in the acute phase
of the disease. One patient (No. 10)
had already been treated by chemo-
therapy, and cells were obtained several
months after the last treatment, when
the patient returned to the hospital in
relapse.
In all but 2 cases the haemoglobin
concentration was less than 11 g/dl, and
only 3 patients had a platelet count
> 100 x 109/1 (Table I). From 51 to
94% of the circulating leucocytes were
blast cells. Muramidase levels were high
in all the patients with AMML and in
the patient with CML. Aspartate trans-
aminase (Asp.T) levels were within the
normal range (5-35 i.u./l) in 5 patients
and elevated in 4 others. Alpha-hydroxy-
butyrate dehydrogenase (HBD) levels in
serum were above the normal range
(0-360 i.u./l) in all the patients studied.
Assays were not carried out if the serum
showed evidence of haemolysis. In the
patients with AML, the mean serum
ferritin concentration was 797 ,ug/l, and
in the patients with AMML, 3990 /ag/l.
In patient 11, the high serum ferritin
concentration of 10,400 ,ug/l was asso-
ciated with highest Asp.T and HBD
activities, but otherwise there was no
correlation between the serum ferritin
concentration and the enzyme activities.
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Leucocyte ferritin concentrations were
24 i 11 (s.d.) fg/cell and 87 i 62 fg/cell
in the patients with AML and AMML
respectively.
Preparation of leucocyte ferritin
About 2 x 1010 leucocytes were iso-
lated from 400-500 ml blood and these
were virtually free of red cells. About
1010 leucocytes were obtained from each
of the 2 normal donors, using the cell
separator. These cells consisted of 9900
neutrophil polymorphs. The assayed fer-
ritin content of the leucocyte extracts
obtained after sonication and centrifuga-
tion ranged from 31 and 39 ,ug for the
normal donors to 2 5 mg in the case
of Patient 10, from whom 19 x 1010 cells
were obtained with the cell separator.
In the leukaemic-cell extracts the assayed
ferritin content accounted for about 0.6%
of the total protein measured by the
Lowry method. After chromatography
on Sepharose 6B the concentrated prep-
arations contained a mean of 64%
(25-75%) of the ferritin originally present
in the cell extract, as determined by
the immunoradiometric assay, and an
average purification of 54-fold was
achieved (0.30 mg ferritin/mg protein). In
the two extracts prepared from the
normal donors recoveries of 58 and 64%
were achieved, with purifications of 500-
and 226-fold. After chromatography on
Sephadex A-50 the mean recovery was
4000 (13-73%) and an average purifica-
tion of 109-fold was achieved (0.61 mg
ferritin/mg protein) for the leukaemic
cells.
Isoelectric focusing (IEF) and anion-
exchange chromatography
IEF was carried out on the concen-
trated preparations obtained after elution
from the Sephadex A-50 column and, in
the case of leucocyte extracts from
Patients 2, 6 and 9, focusing was also
carried out with concentrated prepara-
tions obtained before anion-exchange chro-
matography. Preparations were concen-
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FIG. 1. A diagrammatic representation ofthe
IEF and anion-exchange data obtained
with leucocyte ferritin from 11 patients
with leukaemia (Patients 1-11) and 2
normal subjects (12 and 13). The pl
ranges of normal heart (Ht) and liver (Lv)
are shown as blocks at the top and bottom
on left-hand side. After IEF, leucocyte
ferritin protein was detected by staining
with Coomassie blue, or by immunopreci-
pitation and staining with Coomassie blue
(Worwood et al., 1976a). Faint bands are
indicated by dotted lines. Leucocyte fer-
ritin bands staining directly for Fe are indi-
cated by arrows. Anion-exchange chro-
matography of liver and heart ferritin is
shown at the top right-hand side. Leuco-
cyte ferritin was detected by the immuno-
radiometric assay.
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FIG. 2.-Anion-exchange chromatography of
leucocyte ferritin. Each preparation is
identified by the patient number (see Fig.
1). The ferritin concentration was meas-
ured by immunoradiometric assay ( )
and the chloride ion gradient is also shown
- - ). The chloride ion concentrations
in fractions with maximum ferritin concen-
trations are indicated.
trated until they contained about 200
,ug/ml assayed ferritin. No differences
were found between the IEF patterns
obtained before and after anion-exchange
chromatography. In leucocyte extracts
from Patients 7 and 8, elution was
continued by extending the chloride iron
gradient to 1 M, but no further elution
of ferritin took place.
The results obtained by subjecting
leucocyte ferritin to anion-exchange chro-
matography and IEF are summarized
in diagrammatic form in Fig. 1. Exam-
ples of elution from the anion-exchange
column and photographs of gels are
given in Figs. 2 and 3 respectively. A
wide range of isoferritins are present in
both normal and leukaemic cells. There
is, in general, a good correspondence
between the anion-exchange affinity and
the isoelectric-focusing spectrum of leuk-
aemic ferritin; preparations containing
ferritin with a low affinity for the column
have isoferritins of high pl and vice
versa. Cells were obtained from Patients
7 and 8 on each of two successive days.
After purification, almost identical anion-
exchange elution and IEF patterns were
obtained for the two preparations from
each patient. In order to study the
effect ofenzymic degradation on leucocyte
ferritin, a cell extract was left on the
bench at room temperature for 16 h
(Patient 8). After purification of ferritin
the IEF and anion-exchange patterns
were the same as those from an identical
extract stored at -20'C before purification
of ferritin.
The Fe content ofleucocyteferritin
The extracts were subjectedto density-
gradient centrifugation after anion-ex-
change chromatography and fractions
obtained were assayed for ferritin by
immunoradiometric assay. As found pre-
viously (Worwood et al., 1975) leucocyte
ferritin was always of low density, and
therefore low Fe content, but in some
cases bands staining for Fe could be
detected after IEF. These bands are
marked with arrows in Fig. 1.
DISCUSSION
The results obtained confirm a pre-
vious study of serum and leucocyte
ferritin concentrations in acute leukaemia
(Worwood et al., 1974). If the data
from that paper are combined with the
present data, it can be seen that serum
and leucocyte concentrations in patients
with AMML are 3 x those in patients
with AML (Table II). In patients with
AML, the mean leucocyte concentration
is about 6x that of normal leucocytes
(7 fg/cell), and in patients with AMML,
18 x normal.
There are a number of factors which
are likely to contribute to raised serum
ferritin concentrations in leukaemia:
(1) Most of the patients are anaemic
and have increased amounts of storage
Fe which are reflected by increased
serum ferritin concentrations. This will
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FIG. 3. Isoelectric focusing of ferritin. The pH gradients were formed with ampholytes of pH
range 5-7. The actual gradient at 0-4°C was approximately pH 4.5-6.5. On some occasions
the pH gradient was relatively steep and this is reflected by the more restricted focusing pattern
obtained with the normal liver ferritin included in each run. In each case IEF was carried out
after anion exchange chromatography of leucocyte ferritin. (a) i, Leucocyte ferritin, Patient 9;
ii, normal liver ferritin; both immunoprecipitation. (b) i, Leucocyte ferritin, Patient 2; ii
normal liver ferritin; both inmmunoprecipitation. (c) i, Normal liver ferritin; ii, leucocyte ferritin,
Patient 3; both immunoprecipitation. (d) i, Leucocyte ferritin from Patient 10, direct stain for
protein (Coomassie blue); ii, leucocyte ferritin from Patient 10, immunoprecipitation; iii, normal
liver ferritin, direct stain with Coomassie blue. (e) i, An Fe-rich preparation of normal heart
ferritin; ii, leucocyte ferritin from Patient 4; iii, normal liver. All immunoprecipitation. (f) i,
Normal liver; ii, leucocyte ferritin, Patient 7; iii, normal polymorph ferritin, Patient 12; iv, an Fe-
rich preparation of normal heart ferritin. All immunoprecipitation.
TABLE II. Ferritin Concentrations in Leukaemic Serum and Cells
Serum ferritin Leucocyte ferritin
No. of concentration concentration
Diagnosis patients Pig/l fg/cell
AML 20 774±868 41±38
SP<0-001 SP<0-01
AMML 10 2920±2750j 127±78J
Results are mean ± s.d.
Data from this paper and from Worwood et at. (1974).
provide a relatively small contribution the earlier study, there was a significant
of perhaps another 100 ,ug/l. correlation between leucocyte and serum
(2) Increased synthesis of ferritin ferritin concentration (Worwood et al.,
(White et al., 1974) in the large mass 1974) but in the present group ofpatients,
of leukaemic cells is also reflected in selected for their high leucocyte counts,
high serum ferritin concentrations. In no such correlation was found.ISOFERRITINS IN ACUTE LEUKAEMIA
(3) Abnormal release of ferritin from
damaged cells is another possible cause
of high serum ferritin concentrations,
and the high Asp.T levels in a few of
the patients indicate that this could be an
important factor.
Preliminary examination of leucocyte
extracts on anion-exchange chromato-
graphy showed a highly variable elution
of ferritin (Worwood et al., 1975). The
present study, with much higher concen-
trations of ferritin, demonstrates that
this heterogeneity reflects the presence
of a number of isoferritins in variable
proportions in both normal and leukaemic
cells. In all but one of the leukaemic
ferritin preparations, isoferritins with iso-
electric points corresponding to those of
Fe-rich liver ferritin were present, and
the IEF profile of ferritin from Patient 9
was identical to that of the liver ferritin
with which it was compared (Fig. 1).
In a number of cases, bands were also
seen at a slightly higher pH than the
isoferritins of the Fe-rich liver ferritin
standard, and these resemble similar
isoferritins in serum. Some preparations
also contain more acidic bands of similar
pl to those found in heart ferritin, and
in the case of Patient 3, particularly
acidic isoferritins were seen which also
had a very high affinity for the anion-
exchange column, being incompletely
eluted under the elution conditions gener-
ally selected.
Acidic isoferritins are found in reticulo-
cytes (Worwood et al., 1975) but it does
not seem likely that red cells contributed
to the acidic isoferritins of the leukaemic-
cell preparations. There was no relation-
ship between circulating nucleated red
cells and the presence of acidic isoferritin
(Table I and Fig. 1).
There is a good correspondence be-
tween the elution pattern of leucocyte
ferritin from the anion-exchange column
and its isoelectric-focusing profile. How-
ever, the quantitative significance of
the data obtained by applying the im-
munoradiometric assay to column frac-
tions and density gradients is uncertain.
We have recently shown that the im-
munoradiometric assay very much under-
estimates the concentration of the more
acidic isoferritins found in heart (Wor-
wood, Jones and Jacobs, 1976b). With
immunodiffusion methods, rabbit antisera
to human spleen ferritin appear to
recognize any normal human isoferritin,
so that the detection of ferritin by
immunoprecipitation after IEF is unlikely
to be affected by such differing immuno-
reactivities. Similar findings have been
reported with antisera to liver ferritin
(Arosio et al., 1976; Powell et al., 1975a).
After density-gradient centrifugation the
concentration of more acidic ferritins
would also be underestimated. In only
a few preparations were bands staining
for Fe detected after IEF, thus confirming
that leucocyte ferritin is indeed of low Fe
content.
Since the discovery that, in human
liver tumours and in foetal liver, iso-
ferritins of a more acidic pl than those
found in the normal liver are present
(Alpert et al., 1973) there has been much
interest in the possibility of detecting
" carcinofoetal " ferritin in malignancy
(Arosio et al., 1976; Powell, Halliday and
McKeering, 1975b). However, acidic iso-
ferritins are also widely distributed in
normal tissues such as heart, kidney,
pancreas (Powell et at., 1975a), placenta
(Drysdale and Singer, 1974) and reticulo-
cytes (Worwood et al., 1976a). Normal
liver and spleen seem to be exceptional
in not normally possessing the more
acidic proteins. Powell et al. (1975b)
have shown that serum ferritin from a
patient with a hepatoma contained acidic
isoferritins, and suggested that assays
for circulating acidic isoferritins may be
of use in the study of malignancy. Our
studies with serum from patients with
transfusional Fe overload showed that
acidic isoferritins were present in 2/4
cases (Worwood et al., 1976a) and it
therefore seems unlikely that " acidic "
serum ferritin is specific for malignancy.
Leukaemic cells contain a number of the
isoferritins found in normal tissues, but
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not all preparations contain the more
acidic proteins. Assay of acidic iso-
ferritins is therefore unlikely to be of
any use in the diagnosis of leukaemia or
in the monitoring of treatment. Adel-
man, Arosio and Drysdale (1975) have
proposed that tissue ferritin populations
are composed of molecules made up from
different populations of 3 types of sub-
unit. These subunits are of similar mol-
ecular weight, but can be separated by
electrophoresis in acetic-acid-urea gels.
Arosio et al. (1976) have recently shown
that the subunit types in a lung carcinoma
infiltrating liver appeared to be identical
to those of normal liver and heart. The
range ofisoelectric points ofthe isoferritins
found in leukaemic cells suggests that
in all but one patient the ferritin molecules
would be composed of the normal subunit
types. The very acidic isoferritins found
in the cells from Patient 3 may well
include an abnormal subunit and, al-
though the abnormal isoferritins in this
case were not associated with any specific
clinical feature, the possibility that ab-
normal subunits may occur is worth
exploring in future cases of leukaemia.
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the cell separator.
This study was supported by grants
from the Medical Research Council and
the Leukaemia Research Fund.
REFERENCES
ADELMAN, T. G., ARosIo, P. & DRYSDALE, J. W.
(1975) Multiple Subunits in Human Ferritins:
Evidence for Hybrid Molecules. Biochem. bio-
phy8. Re8. Commun., 63, 1056.
ALPERT, E., COSTON, R. & DRYSDALE, J. W. (1973)
Carcinofoetal Human Liver Ferritins. Nature,
Lond., 242, 194.
ARosIo, P., YOKOTA, M. & DRYSDALE, J. W. (1976)
Structural and Immunological Relationships of
Isoferritins in Normal and Malignant Cells.
Cancer Re8., 36, 1735.
DACIE, J. V. & LEWIS, S. M. (1975) Practical
Haematology. 5th Edn. Edinburgh: Churchill
Livingstone.
DRYSDALE, J. W. & SINGER, R. M. (1974) Carcino-
fetal Human Isoferritins in Placenta and HeLa
Cells. Cancer Res., 34, 3352.
JACOBS, A. & WORWOOD, M. (1975) The Biochemistry
of Ferritin and its Clinical Importance. In
Progress in Hematology, Vol. IX. Ed. E. B.
Brown. New York: Grune & Stratton.
JONES, B. M. & WORWOOD, M. (1975) An Automated
Immunoradiometric Assay for Ferritin. J. clin.
Pathol., 28, 540.
LowRY, 0. H., ROSEBROUGH, N. J., FARR, A. L.
& RANDALL, R. J. (1951) Protein Measurement
with the Folin Phenol Reagent. J. biol. Chem.,
193, 265.
MARCUS, D. M. & ZINBERG, N. (1974) Isolation
of Ferritin from Human Mammary and Pan-
creatic Carcinoma by means of Antibody Im-
munoadsorbents. Arch. Biochem. Biophys., 162,
493.
MARcus, D. M. & ZINBERG, N. (1975) Measurement
of Serum Ferritin by Radioimmunoassay: Results
in Normal Individuals and Patients with Breast
Cancer. J. natn. Canc. Inst., 55, 791.
PARRY, D. H., WORWOOD, M. & JACOBS, A. (1975)
Serum Ferritin in Acute Leukaemia at Presenta-
tion and during Remission. Br. med. J., i,
245.
PARRY, R. M., JR., CHANDON, R. C. & SHAHANI,
K. M. (1965) A Rapid and Sensitive Assay for
Muramidase. Proc. Soc. exp. Biol. Med., 119,
384.
POWELL, L., ALPERT, E., ISSELBACHER, K. J. &
DRYSDALE, J. W. (1975a) Human Isoferritins:
Organ Specific Iron and Apoferritin Distribution.
Br. J. Haematol., 30, 47.
POWELL, L. W., HALLIDAY, J. W. & MCKEERING,
L. V. (1975b) Studies on Serum Ferritin with
Emphasis on its Importance in Clinical Medicine.
In Proteins of Iron Storage and Transport in
Biochemistry and Medicine. Ed. R. R. Crichton.
Amsterdam: Elsevier Press.
WHITE, G. P., WORWOOD, M., PARRY, D. & JACOBS,
A. (1974) Ferritin Synthesis in Normal and
Leukaemic Leucocytes. Nature, Lond., 250, 584.
WORWOOD, M., AHERNE, N., DAWKINS, S. & JACOBS,
A. (1975) The Characteristics of Ferritin from
Human Tissues, Serum and Blood Cells. Clin.
Sci. molec. Med., 48, 441.
WORWOOD, M., DAWKINS, S., WAGSTAFF, M. &
JACOBS, A. (1976a) The Purification and Pro-
perties ofFerritin from Human Serum. Biochem.
J., 157, 97.
WORWOOD, M., JONES, B. M. & JACOBS, A. (1976b)
The Reactivity of Isoferritins in a Labelled
Antibody Assay. Immunochemistry, 13, 477.
WORWOOD, M., SUMMERS, M., MILLER, F., JACOBS,
A. & WHITTAKER, J. A. (1974) Ferritin in Blood
Cells from Normal Subjects and Patients with
Leukaemia. Br. J. Haematol., 28, 27.